quinazolines has been researched along with Rhabdoid Tumor in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billups, CA; Carol, H; Gorlick, R; Houghton, PJ; Keir, ST; Kolb, EA; Lock, R; Maris, JM; Morton, CL; Reynolds, CP; Smith, MA | 1 |
Chi, SN; Forsyth, P; Jayanthan, A; Lun, X; Narendran, A; Obaid, H; Ruan, Y; Singh, A; Smith, A; Strother, D | 1 |
Hosoi, H; Iehara, T; Kita, M; Kuroda, H; Kuwahara, Y; Osone, S; Sugimoto, T | 1 |
DeMattia, JA; Khoshyomn, S; Naraghi, S; Vane, DW | 1 |
4 other study(ies) available for quinazolines and Rhabdoid Tumor
Article | Year |
---|---|
Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program.
Topics: Animals; Antimitotic Agents; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Female; Glioblastoma; Humans; Injections, Intraperitoneal; Kinesins; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Mice, SCID; Osteosarcoma; Quinazolines; Rhabdoid Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Single-Blind Method; Spindle Apparatus; Tumor Stem Cell Assay; Wilms Tumor; Xenograft Model Antitumor Assays | 2009 |
Profiling pathway-specific novel therapeutics in preclinical assessment for central nervous system atypical teratoid rhabdoid tumors (CNS ATRT): favorable activity of targeting EGFR- ErbB2 signaling with lapatinib.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Survival; Cells, Cultured; Central Nervous System Neoplasms; Child; ErbB Receptors; Female; Humans; Infant; Lapatinib; Male; Mice; Molecular Targeted Therapy; Quinazolines; Receptor, ErbB-2; Rhabdoid Tumor; Signal Transduction | 2013 |
Antitumor activity of gefitinib in malignant rhabdoid tumor cells in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Division; ErbB Receptors; Female; Fluorescent Antibody Technique; Gefitinib; Humans; Immunoblotting; Immunoenzyme Techniques; In Vitro Techniques; Infant; Mice; Mice, Inbred BALB C; Mice, Nude; Phosphorylation; Quinazolines; Rhabdoid Tumor; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
Topics: Adult; Cell Division; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Female; Genistein; Humans; Infant; Kidney Neoplasms; Male; Platelet-Derived Growth Factor; Protein Tyrosine Phosphatases; Quinazolines; Receptor Protein-Tyrosine Kinases; Rhabdoid Tumor; Tumor Cells, Cultured; Tumor Stem Cell Assay; Tyrphostins; Wilms Tumor | 2000 |